Income Statement Celyad Oncology SA

Equities

CYAD

BE0974260896

Biotechnology & Medical Research

Market Closed - Euronext Bruxelles Other stock markets 11:55:00 2026-01-12 am EST			5-day change	1st Jan Change
0.1855 ^EUR	-2.11%		-1.59%	+9.12%

25-09-30	Celyad Oncology to Sell Belgian Research Facility for EUR3 Million	MT
25-09-29	Celyad Oncology announces research facility divestiture	RE

d45c0e188a6215f1865b9002.N19EF0IMMBfLti9WrlE5_oyJuMcf1mw78S7w2NjSPO4.Rx0vQQl9WnONxBYe3jNdpOK50b9djyJehGyo7p6DWJ1PPAIlG0NAcqLQZg

Published financial data: CELYAD ONCOLOGY SA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	5K	-	-	102K	186K
Total Revenues	5K	-	-	102K	186K
Cost of Goods Sold, Total	-	-	-	69K	12K
Gross Profit	5K	-	-	33K	174K
Selling General & Admin Expenses, Total	9.39M	10M	10.56M	6.25M	3.2M
R&D Expenses	21.44M	20.69M	18.91M	4.38M	3.24M
Other Operating Expenses	-4.59M	-3.44M	-9.21M	-1.08M	-389K
Other Operating Expenses, Total	26.24M	27.24M	20.26M	9.54M	6.04M
Operating Income	-26.24M	-27.24M	-20.26M	-9.51M	-5.87M
Interest Expense, Total	-297K	-255K	-197K	-82K	-119K
Interest And Investment Income	51K	27K	12K	30K	153K
Net Interest Expenses	-246K	-228K	-185K	-52K	34K
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-136K	5K	173K	-2K	-
Other Non Operating Income (Expenses)	165K	112K	-1K	-	-
EBT, Excl. Unusual Items	-26.46M	-27.35M	-20.28M	-9.57M	-5.84M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	25K	-1K	-190K	1.06M	12K
Asset Writedown	-	-	-35.08M	-	-
Other Unusual Items	9.23M	847K	14.68M	-	-
EBT, Incl. Unusual Items	-17.2M	-26.5M	-40.87M	-8.51M	-5.82M
Income Tax Expense	-	10K	65K	-63K	-
Earnings From Continuing Operations	-17.2M	-26.51M	-40.94M	-8.45M	-5.82M
Net Income to Company	-17.2M	-26.51M	-40.94M	-8.45M	-5.82M
Net Income - (IS)	-17.2M	-26.51M	-40.94M	-8.45M	-5.82M
Net Income to Common Incl Extra Items	-17.2M	-26.51M	-40.94M	-8.45M	-5.82M
Net Income to Common Excl. Extra Items	-17.2M	-26.51M	-40.94M	-8.45M	-5.82M
Per Share Items
Net EPS - Basic	-1.23	-1.7	-1.81	-0.33	-0.14
Basic EPS - Continuing Operations	-1.23	-1.7	-1.81	-0.33	-0.14
Basic Weighted Average Shares Outstanding	13.94M	15.6M	22.59M	25.72M	41.43M
Net EPS - Diluted	-1.23	-1.7	-1.81	-0.33	-0.14
Diluted EPS - Continuing Operations	-1.23	-1.7	-1.81	-0.33	-0.14
Diluted Weighted Average Shares Outstanding	13.94M	15.6M	22.59M	25.72M	41.43M
Normalized Basic EPS	-1.19	-1.1	-0.56	-0.23	-0.09
Normalized Diluted EPS	-1.19	-1.1	-0.56	-0.23	-0.09
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	-25.6M	-26.68M	-19.55M	-9M	-5.69M
EBITA	-26.12M	-27.1M	-19.72M	-9.07M	-5.85M
EBIT	-26.24M	-27.24M	-20.26M	-9.51M	-5.87M
EBITDAR	-25.43M	-26.54M	-19.42M	-8.68M	-5.66M
Effective Tax Rate - (Ratio)	-	-0.04	-0.16	0.74	-
Total Current Taxes	-	10K	65K	-63K	-
Normalized Net Income	-16.54M	-17.09M	-12.67M	-5.98M	-3.65M
Interest on Long-Term Debt	278K	234K	150K	56K	81K
Non-Cash Pension Expense	6K	5K	-1K	75K	44K
Supplemental Operating Expense Items
Marketing Expenses	454K	434K	239K	215K	78K
Selling and Marketing Expenses	454K	434K	239K	215K	78K
General and Administrative Expenses	8.77M	9.42M	10.2M	5.71M	3.09M
Research And Development Expense From Footnotes	21.59M	20.84M	18.99M	4.67M	3.31M
Net Rental Expense, Total	166K	137K	126K	328K	32K
Imputed Operating Lease Interest Expense	98.59K	89.15K	138K	328K	31.04K
Imputed Operating Lease Depreciation	67.41K	47.85K	-11.56K	252	962
Stock-Based Comp., R&D Exp. (Total)	927K	644K	425K	141K	6K
Stock-Based Comp., G&A Exp. (Total)	1.86M	1.53M	1.2M	794K	29K
Stock-Based Comp., Other (Total)	-	-	-	-	1K
Total Stock-Based Compensation	2.78M	2.17M	1.62M	935K	36K

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	17.23M	30.02M	12.44M	7M	4.2M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	17.23M	30.02M	12.44M	7M	4.2M
Accounts Receivable, Total	395K	422K	909K	380K	126K
Other Receivables	512K	1.92M	350K	2.4M	781K
Total Receivables	907K	2.34M	1.26M	2.78M	907K
Inventory	-	-	-	-	417K
Prepaid Expenses	1.34M	1.69M	667K	1.26M	946K
Other Current Assets, Total	220K	246K	454K	77K	45K
Total Current Assets	19.7M	34.29M	14.82M	11.12M	6.52M
Gross Property Plant And Equipment	10.85M	11.09M	1.45M	2.48M	2.42M
Accumulated Depreciation	-6.73M	-7.84M	-1.14M	-653K	-927K
Net Property Plant And Equipment	4.12M	3.25M	309K	1.83M	1.49M
Goodwill	883K	883K	0	0	0
Other Intangibles, Total	34.75M	34.81M	456K	48K	23K
Accounts Receivable Long-Term	2.12M	2.21M	-	-	-
Deferred Charges Long-Term	541K	474K	408K	342K	382K
Other Long-Term Assets, Total	3.97M	4.03M	3.72M	2.94M	1.52M
Total Assets	66.08M	79.94M	19.72M	16.28M	9.93M
Liabilities
Accounts Payable, Total	4.74M	6.61M	4.75M	1.24M	1.23M
Accrued Expenses, Total	1.97M	2.13M	1.39M	496K	443K
Current Portion of Long-Term Debt	37K	-	-	-	-
Current Portion of Leases	1.08M	902K	137K	156K	142K
Unearned Revenue Current, Total	1.84M	1.1M	889K	80K	79K
Other Current Liabilities	2.18M	3.09M	3.26M	957K	949K
Total Current Liabilities	11.83M	13.83M	10.43M	2.93M	2.85M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	2.52M	1.73M	118K	902K	763K
Pension & Other Post Retirement Benefits	614K	53K	13K	1K	1K
Other Non Current Liabilities	20.12M	20.69M	4.84M	6.14M	5.81M
Total Liabilities	35.09M	36.3M	15.4M	9.98M	9.42M
Common Stock, Total	48.51M	78.58M	78.58M	32.95M	8.22M
Additional Paid In Capital	43.35M	6.32M	6.32M	-	-
Retained Earnings	-91.83M	-309M	-350M	-358M	-364M
Comprehensive Income and Other	30.96M	268M	269M	332M	356M
Total Common Equity	30.99M	43.64M	4.32M	6.3M	511K
Total Equity	30.99M	43.64M	4.32M	6.3M	511K
Total Liabilities And Equity	66.08M	79.94M	19.72M	16.28M	9.93M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	14.21M	22.59M	22.59M	41.43M	41.43M
ECS Total Common Shares Outstanding	13.94M	22.59M	22.59M	41.43M	41.43M
Book Value / Share	2.22	1.93	0.19	0.15	0.01
Tangible Book Value	-4.64M	7.94M	3.86M	6.26M	488K
Tangible Book Value Per Share	-0.33	0.35	0.17	0.15	0.01
Total Debt	3.64M	2.63M	255K	1.06M	905K
Net Debt	-13.6M	-27.39M	-12.19M	-5.95M	-3.3M
Debt Equivalent of Unfunded Proj. Benefit Obligation	614K	53K	13K	-	-
Debt Equivalent Oper. Leases	1.33M	1.1M	1.01M	2.62M	256K
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	3.81M	4.01M	1.28M	893K	830K
Full Time Employees	87	95	35	17	17
Part Time Employees	4	6	3	2	2

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-17.2M	-26.51M	-40.94M	-8.45M	-5.82M
Depreciation & Amortization - CF	1.64M	1.3M	827K	285K	347K
Amortization of Goodwill and Intangible Assets - (CF)	115K	134K	547K	438K	18K
Depreciation & Amortization, Total	1.75M	1.44M	1.37M	723K	365K
Amortization of Deferred Charges, Total - (CF)	82K	83K	66K	71K	85K
(Gain) Loss From Sale Of Asset	-25K	1K	-5M	-1.06M	-11K
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	35.08M	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	2.78M	2.17M	1.62M	935K	36K
Other Operating Activities, Total	-12.18M	-5.23M	-16.21M	-930K	-154K
Change In Accounts Receivable	-1.15M	-1.56M	-	-1.2M	631K
Change In Inventories	-	-	-	-	-417K
Change In Accounts Payable	-1.73M	2.96M	-	-5.29M	-391K
Change in Other Net Operating Assets	-	-	-4.02M	-	-
Cash from Operations	-27.66M	-26.64M	-28.01M	-15.2M	-5.68M
Capital Expenditure	-150K	-331K	-123K	-899K	-
Sale of Property, Plant, and Equipment	235K	-	-	1.34M	15K
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	6M	-	-
Sale (Purchase) of Intangible assets	-169K	-62K	-	-35K	-
Investment in Marketable and Equity Securities, Total	-	-	1.09M	-	-
Other Investing Activities, Total	241K	267K	235K	-	-118K
Cash from Investing	157K	-126K	7.2M	407K	-103K
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-1.45M	-1.14M	-896K	-145K	-167K
Total Debt Repaid	-1.45M	-1.14M	-896K	-145K	-167K
Issuance of Common Stock	-	36.57M	-	9.49M	-
Other Financing Activities, Total	6.84M	4.09M	4.14M	10K	3.15M
Cash from Financing	5.4M	39.52M	3.24M	9.36M	2.98M
Foreign Exchange Rate Adjustments	8K	32K	-6K	-1K	-4K
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-22.1M	12.78M	-17.57M	-5.44M	-2.8M
Supplemental Items
Cash Interest Paid	-	-	-	56K	81K
Levered Free Cash Flow	-11.11M	-13.48M	-10.59M	-14.45M	-1.53M
Unlevered Free Cash Flow	-10.92M	-13.32M	-10.46M	-14.4M	-1.45M
Change In Net Working Capital	-1.18M	-401K	742K	9.25M	-1.73M
Net Debt Issued / Repaid	-1.45M	-1.14M	-896K	-145K	-167K

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-21.04	-23.32	-25.41	-33.03	-28
Return on Total Capital	-38.76	-42.08	-49.82	-99.63	-83.59
Return On Equity %	-44.91	-71.05	-170.72	-159.08	-170.92
Return on Common Equity	-44.91	-71.05	-170.72	-159.08	-170.92
Margin Analysis
Gross Profit Margin %	100	-	-	32.35	93.55
SG&A Margin	188K	-	-	6.13K	1.72K
EBITDA Margin %	-512K	-	-	-8.83K	-3.06K
EBITA Margin %	-522K	-	-	-8.9K	-3.15K
EBIT Margin %	-525K	-	-	-9.33K	-3.16K
Income From Continuing Operations Margin %	-344K	-	-	-8.28K	-3.13K
Net Income Margin %	-344K	-	-	-8.28K	-3.13K
Net Avail. For Common Margin %	-344K	-	-	-8.28K	-3.13K
Normalized Net Income Margin	-331K	-	-	-5.86K	-1.96K
Levered Free Cash Flow Margin	-222K	-	-	-14.17K	-821.03
Unlevered Free Cash Flow Margin	-218K	-	-	-14.12K	-781.05
Asset Turnover
Asset Turnover	0	-	-	0.01	0.01
Fixed Assets Turnover	0	-	-	0.1	0.11
Receivables Turnover (Average Receivables)	0.01	-	-	0.16	0.74
Short Term Liquidity
Current Ratio	1.67	2.48	1.42	3.79	2.29
Quick Ratio	1.53	2.34	1.31	3.34	1.79
Operating Cash Flow to Current Liabilities	-2.34	-1.93	-2.69	-5.18	-2
Days Sales Outstanding (Average Receivables)	29.43K	-	-	2.31K	497.84
Average Days Payable Outstanding	-	-	-	15.86K	-
Long Term Solvency
Total Debt/Equity	11.74	6.03	5.91	16.78	177.1
Total Debt / Total Capital	10.5	5.69	5.58	14.37	63.91
LT Debt/Equity	8.15	3.96	2.73	14.31	149.32
Long-Term Debt / Total Capital	7.29	3.74	2.58	12.25	53.88
Total Liabilities / Total Assets	53.1	45.41	78.1	61.28	94.85
EBIT / Interest Expense	-88.35	-106.81	-102.85	-116	-49.33
EBITDA / Interest Expense	-82.46	-101.18	-95.88	-107.18	-46.26
(EBITDA - Capex) / Interest Expense	-82.96	-102.47	-96.5	-118.15	-46.26
Total Debt / EBITDA	-0.15	-0.1	-0.01	-0.12	-0.16
Net Debt / EBITDA	0.56	1.06	0.65	0.68	0.6
Total Debt / (EBITDA - Capex)	-0.15	-0.1	-0.01	-0.11	-0.16
Net Debt / (EBITDA - Capex)	0.55	1.05	0.64	0.61	0.6
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-16.67	-	-	-	82.35
Gross Profit, 1 Yr. Growth %	-16.67	-	-	-	427.27
EBITDA, 1 Yr. Growth %	-11.2	4.22	-26.72	-63.6	-37.06
EBITA, 1 Yr. Growth %	-11.15	3.74	-27.26	-63.56	-35.73
EBIT, 1 Yr. Growth %	-11.03	3.8	-25.61	-62.62	-38.5
Earnings From Cont. Operations, 1 Yr. Growth %	-39.91	54.1	54.4	-79.36	-31.06
Net Income, 1 Yr. Growth %	-39.91	54.1	54.4	-79.36	-31.06
Normalized Net Income, 1 Yr. Growth %	-9.56	3.37	-25.86	-62.43	-39.2
Diluted EPS Before Extra, 1 Yr. Growth %	-46.03	37.69	6.63	-81.87	-57.2
Accounts Receivable, 1 Yr. Growth %	-3.42	6.84	115.4	-58.2	-66.84
Net Property, Plant and Equip., 1 Yr. Growth %	-18.61	-21.15	-90.49	492.23	-18.42
Total Assets, 1 Yr. Growth %	-26.44	20.97	-75.34	-17.42	-39.02
Tangible Book Value, 1 Yr. Growth %	-146.24	-271.38	-51.4	62.03	-92.2
Common Equity, 1 Yr. Growth %	-32.06	40.8	-90.11	46.03	-91.89
Cash From Operations, 1 Yr. Growth %	-1.9	-3.69	5.13	-45.73	-62.64
Capital Expenditures, 1 Yr. Growth %	-64.03	120.67	-62.84	630.89	-
Levered Free Cash Flow, 1 Yr. Growth %	-23.78	21.39	-21.46	4.49	-89.45
Unlevered Free Cash Flow, 1 Yr. Growth %	-23.94	22	-21.45	5.06	-89.93
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-95.99	-	-	-	-
Gross Profit, 2 Yr. CAGR %	-95.99	-	-	-	-
EBITDA, 2 Yr. CAGR %	-9.52	-1.87	-10.5	-41.91	-52.05
EBITA, 2 Yr. CAGR %	-10.09	-3.86	-12.99	-42.14	-51.52
EBIT, 2 Yr. CAGR %	-9.98	-3.9	-12.13	-40.9	-51.97
Earnings From Cont. Operations, 2 Yr. CAGR %	-32.2	-3.77	54.25	-43.55	-62.28
Net Income, 2 Yr. CAGR %	-32.2	-3.77	54.25	-43.55	-62.28
Normalized Net Income, 2 Yr. CAGR %	-8.56	-3.31	-12.46	-40.86	-52.12
Diluted EPS Before Extra, 2 Yr. CAGR %	-39.39	-13.79	21.17	-56.03	-72.14
Accounts Receivable, 2 Yr. CAGR %	19.41	1.58	51.7	-5.11	-62.77
Net Property, Plant and Equip., 2 Yr. CAGR %	16.9	-19.89	-72.61	-24.94	119.81
Total Assets, 2 Yr. CAGR %	-16.29	-5.67	-45.38	-54.87	-29.04
Tangible Book Value, 2 Yr. CAGR %	-51.97	-10.99	-8.74	-11.26	-64.45
Common Equity, 2 Yr. CAGR %	-25.33	-2.19	-62.68	-61.99	-65.6
Cash From Operations, 2 Yr. CAGR %	0.76	-2.8	0.62	-24.46	-54.97
Capital Expenditures, 2 Yr. CAGR %	-57.57	-10.91	-9.45	64.8	-
Levered Free Cash Flow, 2 Yr. CAGR %	-14.6	-3.81	-2.36	3.53	-66.77
Unlevered Free Cash Flow, 2 Yr. CAGR %	-15.21	-3.67	-2.11	3.97	-67.44
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-88.78	-	-	173.24	-
Gross Profit, 3 Yr. CAGR %	-88.18	-	-	87.58	-
EBITDA, 3 Yr. CAGR %	0.68	-5.15	-10.97	-28.28	-40.26
EBITA, 3 Yr. CAGR %	0.1	-5.7	-12.4	-29.63	-40.01
EBIT, 3 Yr. CAGR %	-0.7	-5.61	-11.76	-28.7	-40.04
Earnings From Cont. Operations, 3 Yr. CAGR %	-32.68	-10.86	12.65	-21.11	-39.66
Net Income, 3 Yr. CAGR %	-32.68	-10.86	12.65	-21.11	-39.66
Normalized Net Income, 3 Yr. CAGR %	-4.44	-4.74	-11.5	-28.76	-40.24
Diluted EPS Before Extra, 3 Yr. CAGR %	-40.5	-20.32	-7.46	-35.67	-56.43
Accounts Receivable, 3 Yr. CAGR %	69.58	15.07	30.5	-1.28	-33.16
Net Property, Plant and Equip., 3 Yr. CAGR %	7.78	2.52	-60.62	-23.7	-22.82
Total Assets, 3 Yr. CAGR %	-5.22	-5.36	-39.68	-37.31	-50.11
Tangible Book Value, 3 Yr. CAGR %	-26.69	-26.61	-27.25	10.51	-60.54
Common Equity, 3 Yr. CAGR %	-13.29	-7.75	-54.43	-41.19	-77.29
Cash From Operations, 3 Yr. CAGR %	-14.61	-0.75	-0.23	-18.09	-40.26
Capital Expenditures, 3 Yr. CAGR %	-43.93	-26.48	-33.43	81.64	-
Levered Free Cash Flow, 3 Yr. CAGR %	-12.41	-3.98	-10.1	9.17	-51.61
Unlevered Free Cash Flow, 3 Yr. CAGR %	-12.74	-4.28	-10	9.66	-52.22
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.76	-	-	-49.53	98.73
Gross Profit, 5 Yr. CAGR %	37.97	-	-	-59.73	96.1
EBITDA, 5 Yr. CAGR %	-2.01	2.06	-4.86	-22.04	-27.15
EBITA, 5 Yr. CAGR %	-1.79	1.75	-5.42	-22.43	-27.55
EBIT, 5 Yr. CAGR %	-2.22	1.24	-5.44	-21.73	-27.59
Earnings From Cont. Operations, 5 Yr. CAGR %	-9.99	2.35	-6.21	-25.75	-27.28
Net Income, 5 Yr. CAGR %	-9.99	2.35	-6.21	-25.75	-27.28
Normalized Net Income, 5 Yr. CAGR %	-1.68	2.98	-7.73	-21.28	-27.56
Diluted EPS Before Extra, 5 Yr. CAGR %	-18.5	-7.69	-20.92	-37.19	-42.75
Accounts Receivable, 5 Yr. CAGR %	44.82	50.86	62.19	6.53	-20.98
Net Property, Plant and Equip., 5 Yr. CAGR %	29.38	-1.83	-37.69	-9.5	-21.66
Total Assets, 5 Yr. CAGR %	-16.16	-10.45	-23.97	-29.62	-35.63
Tangible Book Value, 5 Yr. CAGR %	-40.76	-28.37	-19.98	-20.82	-45.37
Common Equity, 5 Yr. CAGR %	-22.59	-13.65	-38.11	-35.3	-59.28
Cash From Operations, 5 Yr. CAGR %	0.26	1.53	-8.82	-11.02	-27.42
Capital Expenditures, 5 Yr. CAGR %	-28.65	-36.66	-32.08	1.54	-
Levered Free Cash Flow, 5 Yr. CAGR %	-0.48	-3.91	-8.52	-1.04	-36.31
Unlevered Free Cash Flow, 5 Yr. CAGR %	-0.7	-4.06	-8.63	-1.06	-36.75